Linc AB

Linc AB is a Sweden-based investment company specializing in the Nordic life sciences sector, particularly pharmaceutical and medical technology companies. It acts as an active, long-term owner, acquiring, managing, and developing product-oriented small and medium-sized enterprises in both private and public markets, with investments typically ranging from SEK 25-250 million per company. Linc AB provides strategic support, capital, industry expertise, and a broad network to portfolio companies, often entering early in drug development phases and later in medtech, while collaborating with management, founders, and boards to unlock potential and drive expansion. Key holdings include MedCap AB, Stille AB, Sedana Medical AB, and C-RAD AB, spanning biotechnology, pharmaceuticals, and medical devices. Headquartered in Stockholm with a lean team of two employees, Linc AB plays a vital role in fostering innovation within the life sciences ecosystem, contributing to global healthcare advancements through efficient resource allocation and ambitious growth initiatives in the Nordic region.